 immediate EVAR with surveillance for AAAs between 4.1 and
5.4 cm (CAESAR) and 4.0 and 5.0 cm (PIVOTAL) and
found no survival beneﬁt for early EVAR, but neither
trial was designed to determine whether immediate
EVAR might be beneﬁcial or harmful for speciﬁc AAA
size ranges or age subgroups. A Cochrane database
review280 of these four